Key points are not available for this paper at this time.
The main aim of the study was to evaluate the effect of anoac® cream treatment on the management of Haemorrhoids, Fissures and Fistulas in comparison with marketed ointment.It was a prospective, observational, open-label, comparative and single centre clinical study conducted on 60 Haemorrhoids, Fissures and Fistulas patients. Adult patients of either sex, 18 years or older, referred to the Healing Hands Clinic, Pune, India, for haemorrhoids, fissures and fistulas were study candidates. Some patients were given ananoac® cream treatment, while others were given marketed ointment. 60 patients were included and no side effects were reported during the entire study period. The anoac® cream treatment group exhibited a significant difference in symptoms with P values < 0.05. In contrast, the marketed ointment showed a very slight difference in symptoms, which was inferior to the anoac® treatment group. An examination of the proposed doctor and patients revealed that almost all patients in the anoac® cream treatment group made excellent progress when compared with the marketed ointment. This study concludes that the anoac® cream formulation provides more relief than the marketed ointment for treating haemorrhoids, fissures, and fistulas. It is also well-tolerated, safe, and effective.
Porwal et al. (Wed,) studied this question.